Clinical Trial Update: Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating post-discharge risk-based management in patients undergoing high-risk elective major cancer surgeries; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Surgery, Cancer | Phase 3 | Status: RECRUITING